Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-11-26

Clinical Trial Update: Outcome of Omega 3 FA and Punctal Plugs on Ocular Surface Disease [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating omega-3 fatty acids and punctal plugs for ocular surface disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Omega-3 fatty acids (omega-3 fatty acids)
  • punctal plugs (punctal plugs)

Snippet

Sponsor: Benha University | Conditions: Ocular Surface Disease | Phase 4 | Status: COMPLETED